Skip to main content
. Author manuscript; available in PMC: 2007 Mar 6.
Published in final edited form as: J Steroid Biochem Mol Biol. 2006 Nov 7;102(1-5):128–138. doi: 10.1016/j.jsbmb.2006.09.003

Fig. 7.

Fig. 7

E2 plus FUL-stimulated growth of MCF-7/RAL2 tumors. Data are from Figure 3 on day 42 and shown as a histogram, but supplemented with the additional group of 5 ovariectomized athymic mice (10 tumors) treated with 0.3 cm E2 capsule sc plus 2 mg/day FUL sc. The cross-sectional area of E2 plus FUL-treated MCF-7/RAL2 tumors was significantly different from that of Control-treated, E2-treated, and FUL-treated MCF-7/RAL2 tumors (all P-values < 0.0001).